Last updated: September 12, 2026

Federal regulation is quoted here, and none of it is legal advice. Confirm the wording against the current CMS text and your own counsel.

What a Scope of Appointment is and when it is required

A Scope of Appointment records which product types a beneficiary agreed to discuss, and 42 CFR 422.2264(c)(3)(i) requires it agreed and recorded before a personal marketing appointment. Under the CY2027 rule effective October 1, 2026, the 48 hour waiting period between the SOA and the appointment is gone. What the form has to capture is unchanged.

The waiting period is the part that traveled. An agency collecting an SOA on Tuesday could not sit down with that beneficiary until Thursday, so a beneficiary who called in ready to talk got a callback two days out instead. That constraint goes away with the CY2027 marketing provisions on October 1, 2026, fourteen days before the Annual Enrollment Period opens.

Everything else sits where it was. The text at 42 CFR 422.2264(c)(3)(i) carries no waiting period and one plain requirement:

"Prior to the personal marketing appointment, the MA plan (or agent or broker, as applicable) must agree upon and record the Scope of Appointment with the beneficiary(ies)."

A written SOA is required for the in person version of that appointment, and Part D carries the same language at 42 CFR 423.2264. Whether any of this reaches your arrangement depends on how you are paid rather than what your business card says, which is the question what a TPMO is settles.

The inbound call a beneficiary started

A call placed to you by a beneficiary is not unsolicited contact. 42 CFR 422.2264(a)(3) puts calls outside the unsolicited category when the beneficiary consents or initiates the contact, and returning a call or dialing a person who sent in a business reply card lands on the same side of that line.

That answers a narrower question than the one most agents ask with it. Unsolicited contact and personal marketing appointment are separate provisions in the same section, and an inbound call turns into an appointment the moment it moves to plan specific discussion. Treating the exemption as a blanket pass on the SOA is a reading we would not act on without counsel, because the regulation does not say it anywhere we could find.

What changed under the CY2027 rule

One row in this table is different from the others.

ItemBeforeUnder the CY2027 rule, effective 2026-10-01
Wait between the SOA and the appointment48 hoursNone
The SOA itselfAgreed and recorded before a personal marketing appointmentAgreed and recorded before a personal marketing appointment
Written form for in person appointmentsRequiredRequired
Discussion limited to the agreed lines of businessRequiredRequired
SOA validity12 months from the beneficiary's signature date12 months from the beneficiary's signature date

The disclaimer rules moved in the same cycle and get conflated with this one constantly, so if your season prep is one document, put the TPMO disclaimer timing next to this page.

What did not change

An agency that read a headline about the 48 hour rule and concluded the form went away has a worse problem this October than the one that kept a stale process. The requirement, the writing standard for in person appointments, and the limit on what can be discussed all survived intact.

Scheduling is where the gain lands, and it is narrow. You can collect an SOA and hold the appointment in the same hour, which for an inbound call at the top of AEP is most of what the old rule cost you. The document it produces is the same document it was in August.

What the form has to capture

The section lists what a plan, agent, or broker may not do during an appointment. One item reads:

"Market any health care related product during a marketing appointment beyond the scope agreed upon by the beneficiary, and documented by the plan in a Scope of Appointment, business reply card, or request to receive additional information, which is valid for 12 months following the date of beneficiary's signature date or the date of the beneficiary's initial request for information."

So the regulation names the scope the beneficiary agreed to, a signature date, and a 12 month clock running from it. A field list is not in there. The product type checkboxes, the agent name, and the appointment date on the form in your agency's folder come from the plan's own document rather than from 422.2264, which is worth knowing before somebody builds a house version off a blog post.

Format follows where the appointment happens. Writing is required for in person appointments under (c)(3)(i), and a recorded telephonic SOA is common for phone appointments, which reads as practice built around the paragraph rather than a rule stated inside it.

Staying inside the scope once the appointment starts

Scope is where agencies actually get in trouble, and it has nothing to do with the form. Paragraph (c)(3)(iii)(B) prohibits marketing additional health related lines of plan business that were not identified before the appointment "without a separate Scope of Appointment, identifying the additional lines of business to be discussed."

Say a beneficiary signs for Medicare Advantage and, twelve minutes in, asks what you can do about her prescriptions. A standalone drug plan is a second line of business. Answering her in that moment is the natural thing to do, and it is also the violation. The fix is a separate SOA covering the line she just raised.

Scope drift almost never looks like an agent going off script. It shows up as a helpful answer to a question the beneficiary asked, which makes it harder to coach out of a floor than a missing document. Agents who feel rude redirecting a direct question will keep drifting until a supervisor plays them a call where it happened.

How an SOA shows up on a recorded call

Once a call is transcribed with the speakers separated, two things become searchable: whether an SOA was confirmed on the line, and which product names came up afterward. A drug plan discussed under an MA only scope is a mismatch you can find by search rather than by listening, and searchable transcripts with timestamps put the evidence at a second instead of in a reviewer's memory.

On a Medicare sales call scorecard the SOA criterion carries 8 points as an auto fail, with scope adherence worth 7 more as an ordinary deduction. That split is our editorial judgment rather than a CMS weighting. A missing SOA voids the call, and a stray product mention is a coaching conversation, so they should not fail the same way.

Two limits worth stating. Machine scoring holds up on rule based criteria like whether a phrase was said and when, and it gets shakier on tone, which Aircall and StackAI both note about automated scoring generally. The larger limit on this particular rule is that a paper SOA signed at a kitchen table leaves nothing on the audio at all, so the recording tells you what was discussed while your form file tells you what was agreed. Reconciling those two is still a person with two screens open.

Manual upload takes a folder of last season's calls without touching your dialer. Trinsic runs its own model on its own infrastructure, so beneficiary names and plan details stay inside that environment, which is the first question a plan partner asks. More on call QA for Medicare agencies.

Frequently asked questions

Is the 48 hour scope of appointment rule gone?

Yes, under the CY2027 final rule whose marketing provisions take effect October 1, 2026. The current text at 42 CFR 422.2264 carries no waiting period between the Scope of Appointment and the appointment. Agreeing and recording the SOA before that appointment is untouched.

Do you need a scope of appointment for an inbound call?

A call the beneficiary initiated is not unsolicited contact under 42 CFR 422.2264(a)(3), which is a separate question from whether an SOA is required. The SOA obligation attaches to a personal marketing appointment, and an inbound call becomes one when plan specific discussion starts. Ask counsel about your own call flow.

How long do you keep a scope of appointment?

42 CFR 422.2264 sets a 12 month validity running from the beneficiary's signature date, and it does not state a retention period. Your plan contracts usually do. Recording retention is a separate rule with its own clock, covered in CMS call recording requirements.

What happens if you discuss a product not on the SOA?

Marketing a health related line of business outside the agreed scope is prohibited at 42 CFR 422.2264(c)(3)(iii). A separate Scope of Appointment identifying the additional line is what the paragraph asks for. Consequences run through your plan contracts and your upline rather than through a published penalty schedule.

Where agencies get this wrong in practice

Two failure modes are worth an hour of your time this month. The expensive one is an agency that heard the rule changed and quietly stopped collecting the form, which leaves every personal marketing appointment this season undocumented. Cheaper, and still real, is the agency enforcing a 48 hour wait it no longer owes and paying for it in appointments that never get rebooked.

Underneath both sits a distinction that survives every rule cycle. A signed form proves a beneficiary gave permission to discuss a product category. It says nothing about whether the agent stayed inside that category once the call started, and the second fact is the one a plan partner is actually asking about when they ask how you manage scope. A recorded call, transcribed and scored against the lines of business on the form, is where that gap closes.

Last AEP had a week with more appointments on it than any other. Those calls are still sitting in the archive, and scoring them answers the drift question. Schedule a demo and bring that week.

Sources

  • Scope of Appointment requirement, 42 CFR 422.2264(c)(3)(i), read via Cornell LII on 2026-09-12. Page shows most recent amendment 91 FR 17583, April 6, 2026. Verified against a primary text mirror. Read it again on eCFR before publishing.
  • Scope limits and the 12 month validity, 42 CFR 422.2264(c)(3)(iii)(A) and (B), read via Cornell LII on 2026-09-12. Verified against a primary text mirror.
  • Unsolicited contact and beneficiary initiated calls, 42 CFR 422.2264(a)(2) and (a)(3), read via Cornell LII on 2026-09-12. Verified against a primary text mirror.
  • Part D counterpart, 42 CFR 423.2264, read via Cornell LII on 2026-09-12. Page shows most recent amendment 91 FR 17592, April 6, 2026. Verified against a primary text mirror.
  • Elimination of the 48 hour waiting period, and the October 1, 2026 effective date for the CY2027 marketing provisions, attributed to CMS-4208-F3. Secondary, from agent facing summaries gathered 2026-09-08. Not read against the final rule. Verify against the Federal Register publication.
  • Annual Enrollment Period opening October 15. Standard CMS enrollment calendar, widely established. Confirm on cms.gov or medicare.gov before publishing.
  • Telephonic Scope of Appointment as accepted practice for phone appointments. Industry custom, unverified against primary text.
  • Retention period for Scope of Appointment documentation. Not stated at 42 CFR 422.2264 and not sourced elsewhere, so this page gives no number.
  • Aircall and StackAI, on AI call scoring being more reliable on rule based criteria than on subjective tone. Third party, gathered 2026-09-08. Unverified.
  • The 8 point auto fail and 7 point deduction weighting for SOA criteria. Editorial judgment carried over from the Medicare sales call scorecard.